Clarity Pharmaceuticals Ltd (ASX:CU6)
Australia · Delayed Price · Currency is AUD 1.815
-0.225 (-11.03%)
Jun 26, 2026, 4:10 PM AEST
Clarity Pharmaceuticals Market Cap
Clarity Pharmaceuticals has a market cap or net worth of 675.65 million as of June 26, 2026. Its market cap has decreased by -6.14% in one year.
Market Cap
675.65M
Enterprise Value
449.40M
Revenue
10.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.82
Market Cap Chart
Since August 25, 2021, Clarity Pharmaceuticals's market cap has increased from 384.20M to 675.65M, an increase of 75.86%. That is a compound annual growth rate of 12.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 675.65M | -46.27% |
| Dec 31, 2025 | 1.26B | -6.00% |
| Dec 31, 2024 | 1.34B | 168.49% |
| Dec 29, 2023 | 498.26M | 93.82% |
| Dec 30, 2022 | 257.07M | 35.63% |
| Dec 31, 2021 | 189.54M | -50.67% |
| Aug 25, 2021 | 384.20M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mesoblast | 2.70B |
| Neuren Pharmaceuticals | 1.61B |
| PYC Therapeutics | 1.51B |
| Clinuvel Pharmaceuticals | 506.80M |
| Racura Oncology | 458.33M |
| Tetratherix | 329.47M |
| Starpharma Holdings | 290.59M |
| Orthocell | 196.02M |